Make an inquiry
Refer a patient
833 367-6942
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
833 367-6942
Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
833 367-6942
Healthcare Professionals
Latest research
Publications
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer
20 Jan 2019
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer
Written by
Shore Neal D., MD, FACS
Petrylak DP, Kantoff P, Vogelzang NJ, Mega A, Fleming MT, Stephenson JJ Jr, Frank R, Dreicer R, McClay EF, Berry WR, Agarwal M, DiPippo VA, Rotshteyn Y, Stambler N, Olson WC, Morris SA, Israel RJ.
Back to top
